KIR2DL3, Fc fusion, Biotin-labeled (Human) Recombinant

BPS Bioscience

KIR2DL3, Fc fusion, Biotin-labeled (Human) Recombinant

7

Research Use Only

Biotin

KIR2DL3

killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3

CD158B2, CD158b, GL183, KIR-023GB, KIR-K7b, KIR-K7c, KIR2DL, KIR2DS5, KIRCL23, NKAT, NKAT2, NKAT2A, NKAT2B, p58, killer cell immunoglobulin-like receptor 2DL3, CD158 antigen-like family member B2, NKAT-2, killer cell immunoglobulin-like receptor two domains long cytoplasmic tail 3, killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5, killer inhibitory receptor cl 2-3, natural killer associated transcript 2, natural killer cell inhibitory receptor KIR2DL3, p58 NK receptor CL-6, p58 natural killer cell receptor clone CL-6, p58.2 MHC class-I specific NK receptor

Killer cell immunoglobulin-like receptor 2DL3

Human KIR2DL3, also known as Killer cell immunoglobulin-like receptor 2DL3, KIR2DS5 and KIRCL23. GenBank Accession No. NM_015868. a.a. 22-245 fused at the C terminus to the Fc portion of human IgG1 followed by a C-termina Avi-tag™ and expressed in a HEK293 cell expression system. MW=53 kDa This protein is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation is confirmed to be ≥90%. This protein runs at a higher MW due to glycosylation.

-80°C,2°C to 8°C

41116100

Human